Update: Please find now coronavirus statement issued by Syn-Tech, Taiwan below attached.
As the coronavirus continues to spread in China, the Chinese Government extended the New Year holiday one additional week to February 9th. Some API factories may not re-open until the 16th to help contain the spread of the virus.
API shortages will be expected due to the extension of Chinese New Year.
Transo-Pharm has a significant stock of Epinephrine Base and Bitartrate manufactured by Syn-Tech (Taiwan) available to our global customers. The raw materials are supplied from Europe and there is enough stock available to produce (input estimated amount here) kg if needed.
Transo-Pharm does not expect any shortages in supply due to the coronavirus.
Coronavirus outbreak in China may disrupt global drug supply chains - but not at Transo-Pharm !
We at Transo-Pharm assure always continuous supply of API Phenylephrine HCL from our CMO, Hisoar, China.
The Coronavirus has no negative impact on our supply chain.
Due to extended stocks Transo-Pharm is able to supply the markets from their warehouse in Germany without any disruption. The next production campaign of the API will start earlier in order to have more time for production, release and the transport out of China. A continuous supply of API for the global customers is guaranteed.
Please find our update here